This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone
Menu
keyboard_arrow_right

DAY THREE - GMT (Greenwich Mean Time)

keyboard_arrow_leftSearch & Filter
search

DAY THREE - GMT (Greenwich Mean Time)

search
09:55 - 10:005 mins
Welcome to Day Three
  • Louisa Maitland - Conference Director, Informa
10:00 - 10:5050 mins
Covid-19 Learnings
PANEL: Impact of Running Clinical Trials during the Pandemic and Lessons Learnt
  • Olivia Barnes - Senior Research Nurse, Shelbourne Medical Centre in Leamington
  • Raquel Benedí - Cluster Head Clinical/PV Quality, Novartis Pharma GmbH
10:00 - 10:2525 mins
Operations
The Future of Primary Care Research – A Hybrid Model
  • Hayley Lewis - Research Nurse, Albany House Medical Centre
10:00 - 10:2525 mins
Decentralized Trials
CASE STUDY: What do Decentralized Clinical Need to be Successful and Sustainable?
  • Marc Fischer - Senior Director, FASTR (Feasibility, Activations and Strategy & Tactics of Recruitment), Vertex Pharmaceuticals
  • Rudi Ladenius - Associate Director, Global head Site Advocacy & Regional Site Advocate (Central Europe and Middle East), Vertex
10:25 - 10:5025 mins
Operations
Spotlight Presentation:
    10:25 - 10:5025 mins
    Decentralized Trials
    CASE STUDY: Executing a Completely Decentralized, Randomised, Controlled Clinical Trial
    • Mary C. Birmingham - Director, Clinical Scientist, Janssen Scientific Affairs, LLC
    10:50 - 11:1525 mins
    Covid-19 Learnings
    Projecting How Protocol Designs Will Change Post Pandemic
    • Kenneth Getz - Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Founder and Board Chair, CISCRP
    10:50 - 11:4050 mins
    Operations
    PANEL C: Ensuring a good Recruitment and Retention Strategy
    • Hayley Lewis - Research Nurse, Albany House Medical Centre
    • Andre Krzeminski - Lead Research GP, Albany Health, UK
    • Wolfgang Eglmeier - Head Centre for Clinical Studies, Witten/Herdecke University
    • Marisol Montolio del Olmo - Scientific Director of Duchenne Parent Project, adjunct Professor at the University of Barcelona
    10:50 - 11:1525 mins
    Decentralized Trials
    Spotlight Presentation:
      11:15 - 11:4025 mins
      Covid-19 Learnings
      Spotlight Presentation:
        11:15 - 11:4025 mins
        Decentralized Trials
        CASE STUDY: Bringing Trials Closer to Patients: Learnings from a Fully Decentralised Trial in Ocology
        • Elizabeth Theogaraj - Global Regulatory Lead, Roche
        11:40 - 12:0525 mins
        Covid-19 Learnings
        CASE STUDY: Running Cancer Trials Running During the Pandemic and Beyond
        • Stephen Nabarro - Head of Clinical Operations and Data Management, Cancer Research UK Centre for Drug Development
        11:40 - 12:0525 mins
        Operations
        Avoca Share Data - Research of Adoption of Innovation
        • Patricia Leuchten, - President & Chief Executive Officer,, Avoca Group, USA
        11:40 - 12:0525 mins
        Decentralized Trials
        The latest on DEEP - Digital Endpoints and Protocols
        • Kai Langel - Director, Janssen Clinical Innovation (JCI), Janssen-Cilag GmbH, Johnson & Johnson, Belgium
        12:05 - 13:0055 mins
        LIVE Virtual Showcase Hub Networking Tech Tours Roundtables
          13:00 - 13:055 mins
          Closing Plenary Remarks
            13:05 - 13:3530 mins
            CLOSING PLENARY
            Business and Financial Analysis and Impact of Mergers and Acquisition of CRO’s and Industry landscape
            • Neal McCarthy - Managing Director, Fairmount Partners
            13:35 - 14:0530 mins
            CLOSING PLENARY
            Modernizing Clinical Trial Conduct: Trends and Opportunities
            • Simon Trowell - Vice President, Clinical Development Quality & Risk Management, GSK
            14:05 - 14:3530 mins
            CLOSING PLENARY
            Plenary: Spotlight Presentation:
              14:35 - 15:0530 mins
              CLOSING PLENARY
              Plenary: Spotlight Presentation:
                15:05 - 15:5045 mins
                CLOSING PLENARY
                PANEL: Post-COVID – Keeping Momentum of the Adoption of New Ways of Working and New Technology
                • Craig Lipset - Founder & Advisor, Clinical Innovation Partners, Co-Chair, Decentralized Trials & Research Alliance (DTRA)
                • Gail Francis - Expect Inspector, GCP, Medicines and Healthcare Products Regulatory Agency (MHRA)
                • Dalvir Gill - Chief Executive Officer, TransCelerate Biopharma Inc.,
                • Kirsty Wydenbach - Senior Medical Assessor and Deputy Unit Manager, Clinical Trials Unit, Medicines and Healthcare Products Regulatory Agency (MHRA)
                • Leanne Madre - Acting Executive Director, Clinical Trials Transformation Initiative (CTTI)
                15:50 - 16:0010 mins
                CLOSING PLENARY
                Lifetime Achievement Award
                  16:00 - 16:4545 mins
                  CLOSING PLENARY
                  LIVE Virtual Showcase Hub Networking Tech Tours Roundtables
                    16:45 - 16:505 mins
                    End of Conference
                      DAY TWO
                      Filter
                      Streams
                      Formats
                      Choose Day